Katherine L. Nathanson

University of Pennsylvania

Full Professor(heuristic)

BRCA gene mutations in cancer · Genetics

Compare more Genetics professors.

h-index114
i10-index370
Publications1,123
Citations50,056

Grants

13 total · 4 active

NIH #R01CA304177

Establishing the role of hypomorphic BRCA1 and BRCA2 variants in cancer risk, etiology and response to therapy

Active
Amount
$700K–$800K
Period
2026-06-01 → 2031-05-31
PIs
3

Awarded at MAYO CLINIC ROCHESTER

NIH #U01HG014629

Population genomic screening in primary care practices serving an urban population

Active
Amount
$900K–$1000K
Period
2026-06-23 → 2031-03-31
PIs
4

NIH #R01HG012670

Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System

Active
Amount
$900K–$1000K
Period
2022-09-09 → 2027-06-30
PIs
3

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

13 total · 4 active

NIH #R01CA304177

Establishing the role of hypomorphic BRCA1 and BRCA2 variants in cancer risk, etiology and response to therapy

Active
Amount
$700K–$800K
Period
2026-06-01 → 2031-05-31
PIs
3

Awarded at MAYO CLINIC ROCHESTER

NIH #U01HG014629

Population genomic screening in primary care practices serving an urban population

Active
Amount
$900K–$1000K
Period
2026-06-23 → 2031-03-31
PIs
4

NIH #R01HG012670

Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System

Active
Amount
$900K–$1000K
Period
2022-09-09 → 2027-06-30
PIs
3

NIH #T32HG009495

Postdoctoral Training Program in Genomic Medicine

Active
Amount
$500K–$600K
Period
2017-07-21 → 2027-06-30
PIs
2

NIH #U01CA232836

Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer

Amount
$4M–$5M
Period
2019-09-20 → 2026-08-31
PIs
2

NIH #U01CA164947

Post genome wide association studies in testicular germ cell tumors

Amount
$1M–$2M
Period
2012-09-21 → 2025-08-31
PIs
2

NIH #R01LM012601

Biomedical Computing and Informatics Strategies for Precision Medicine

Amount
$300K–$400K
Period
2017-09-01 → 2021-08-31
PIs
3

NIH #R01CA176785

Identifying and validating novel susceptibility genes for breast cancer

Amount
$600K–$700K
Period
2014-04-10 → 2019-08-31
PIs
2

Awarded at MAYO CLINIC ROCHESTER

NIH #R01CA192393

Risk and penetrance of mutations from breast cancer testing panels.

Amount
$1M–$2M
Period
2014-09-25 → 2019-08-31
PIs
3

Awarded at MAYO CLINIC ROCHESTER

NIH #R21CA185953

Investigating the association between the somatic and inherited genetics of pheoc

Amount
$100K–$200K
Period
2014-09-12 → 2016-08-31
PIs
1

NIH #P30CA016520

Cancer Control Research Program

Amount
<$100K
Period
— → —
PIs
1

NIH #P01CA210944

Core C: Immune bioinformatics and biostatistics

Amount
$300K–$400K
Period
— → —
PIs
1

NIH #P50CA174523

Association of Inherited Variation in Immune Mediated Adverse Events and Respons

Amount
$300K–$400K
Period
— → —
PIs
1

Awarded at WISTAR INSTITUTE

Recent Public Signals

  1. New NIH award: Population genomic screening in primary care practices serving an urban population2026-06-23
  2. New paper: Supplementary Data from Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer2026-06-17
  3. New NIH award: Establishing the role of hypomorphic BRCA1 and BRCA2 variants in cancer risk, etiology and response to therapy2026-06-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-6740-0901

Professor Insights

Career Trajectory